Trends in cell collection and apheresis practices: Insights from a cross-sectional study on the use of Spectra Optia in collection and transplant centers
This study highlights the breadth of indications for which Spectra Optia is used, and the dynamic nature and growth prospects of the field. Innovation and standardization in apheresis technologies will be important to drive the potential of cell-based therapeutics.
Authors
- Tomoko Henzan
- Nabih Azar
- Nelson Jen An Chao (ORCID: https://orcid.org/0000-0001-6725-7220)
- Matthew Cawson (ORCID: https://orcid.org/0000-0001-7175-0720)
- Tayler C Kent (ORCID: https://orcid.org/0000-0003-4478-5375)
- Tsiporah B. Shore (ORCID: https://orcid.org/0000-0001-6033-0747)
- Pascale Poullin (ORCID: https://orcid.org/0000-0002-2748-4354)
- Franziska Waltl
- Maria Geske
- Hugo Fabre
- Manuel Cliquennois
Institutions
- Duke University (US)
- Cornell University (US)
- Universitätsmedizin Greifswald (DE)
- Sorbonne Université (FR)
- Hôpital de la Conception (FR)
- Kyushu University Hospital (JP)
- Mount Sinai Hospital (US)
- Pitié-Salpêtrière Hospital (FR)
- Duke Medical Center (US)
- Établissement Français du Sang (FR)
- Terumo (Germany) (DE)
Publication Details
- Journal
- Transfusion and Apheresis Science
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1016/j.transci.2025.104251
- Citations
- 1
- Primary Topic
- Organ and Tissue Transplantation Research
- Type
- article
- Field-Weighted Citation Impact
- 1.99
Funders
- Terumo BCT